Cargando…

TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization

Prostate cancer is the second leading cause of cancer-related death in the United States. As a first line treatment for hormone-refractory prostate cancer, docetaxel (DTX) treatment leads to suboptimal effect since almost all patients eventually develop DTX resistance. In this study, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yixiang, Zhang, Baotong, Xiang, Lingwei, Xia, Siyuan, Kucuk, Omer, Deng, Xingming, Boise, Lawrence H., Dong, Jin-Tang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359077/ https://www.ncbi.nlm.nih.gov/pubmed/32685011 http://dx.doi.org/10.7150/thno.44567

Ejemplares similares

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2021)

Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration
por: Zhang, Baotong, et al.
Publicado: (2020)

Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer
por: Huang, Qingqing, et al.
Publicado: (2023)

BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth
por: Deng, Jiusheng, et al.
Publicado: (2016)

Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative
por: Zhang, Shumin, et al.
Publicado: (2016)

Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells
por: Xing, Changsheng, et al.
Publicado: (2013)

BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
por: Gupta, Vikas A, et al.
Publicado: (2021)

Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1
por: Grieco, Amanda J., et al.
Publicado: (2015)

KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation
por: Ci, Xinpei, et al.
Publicado: (2015)

KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy
por: Jia, Jing, et al.
Publicado: (2019)

KLF5 Is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells
por: Li, Juan, et al.
Publicado: (2020)

KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy: Erratum
por: Jia, Jing, et al.
Publicado: (2023)

Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells
por: OGURA, TAKEHARU, et al.
Publicado: (2016)

Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer Cells
por: Mohammadian, Jamal, et al.
Publicado: (2016)

Targeting Bcl2 in cancer
por: Chen, Guo, et al.
Publicado: (2015)

Roles of Klf5 Acetylation in the Self-Renewal and the Differentiation of Mouse Embryonic Stem Cells
por: Zhao, Tong, et al.
Publicado: (2015)

Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34(+) HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
por: Lamsfus-Calle, Andrés, et al.
Publicado: (2020)

KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling
por: Memon, Azra, et al.
Publicado: (2018)

Identification of KLF9 and BCL3 as transcription factors that enhance reprogramming of primordial germ cells
por: Otsuka, Kei, et al.
Publicado: (2018)

Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
por: Tamaki, Hiroki, et al.
Publicado: (2014)

Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling
por: Liu, Zhongyuan, et al.
Publicado: (2019)

Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference
por: Fu, Yu-Ke, et al.
Publicado: (2022)

Undifferentiated prostate cancer treated with docetaxel
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Dexamethasone treatment promotes Bcl-2-dependence in multiple myeloma resulting in sensitivity to Venetoclax
por: Matulis, Shannon M., et al.
Publicado: (2015)

Targeting aldehyde dehydrogenase for prostate cancer therapies
por: Ma, Miao, et al.
Publicado: (2022)

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer
por: Scagliotti, G V, et al.
Publicado: (2006)

Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis
por: Chen, Xi, et al.
Publicado: (2016)

Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation
por: Erdmann, Kati, et al.
Publicado: (2017)

Mitochondrial Depolarization During TNF-induced Apoptosis is Caspase-dependent and Independent of Bcl-x L and the Permeability Transition Pore
por: Cepero, E., et al.
Publicado: (2001)

Bcl2 inhibition of mitochondrial DNA repair
por: Xie, Maohua, et al.
Publicado: (2015)

Molecular mechanisms of docetaxel resistance in prostate cancer
por: Sekino, Yohei, et al.
Publicado: (2020)

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
por: Francini, Filippo, et al.
Publicado: (2011)

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
por: Omoboyede, Victor, et al.
Publicado: (2023)

Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy
por: Yu, Yang, et al.
Publicado: (2021)

A simple method to improve the stability of docetaxel micelles
por: Zhang, Lan, et al.
Publicado: (2016)

Structurally-discovered KLF4 variants accelerate and stabilize reprogramming to pluripotency
por: Borisova, Evgeniia, et al.
Publicado: (2021)

Platelet derived TGF-β promotes cervical carcinoma cell growth by suppressing KLF6 expression
por: He, Ao-Di, et al.
Publicado: (2017)

d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis
por: Rabi, Thangaiyan, et al.
Publicado: (2009)

CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
por: Lai, Chih-Jen, et al.
Publicado: (2019)

KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone
por: Tassone, Evelyne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kku1cdn5uc6ncd9t3pe73un7kr